Zhi Wen
温治
Zhi Wen (温治) is the general manager of SSCI Leading Fund (上海国投先导基金 / 上海国投先导私募基金管理有限公司), a Shanghai state-backed fund that, per a Dalton Venture report, "has long focused on technological innovation and industrial development" and backs innovative companies through capital . He appears in partner coverage mainly in this capacity — delivering opening remarks at a Dalton Venture AI-for-science event in August 2026 , and joining a Qiming Venture Partners RMB-fund summit panel in May 2025 alongside CCB Emerging Investment's Wang Wenhuai and Oriza's Xu Qing on the ideal state of RMB funds and GP practices . Beyond these appearances, elsewhere's corpus has no deeper profile of him personally.
AI-generated — may contain errors, please verify.
Coverage
When AI Starts Doing Science: A Recap of the SSCI Leading Fund × Dalton Venture Tong Academy Event
Scientific exploration has no end point, and innovation in the age of intelligence has only just begun.
What Happens After AI Starts Doing Science? | Dalton Venture AI4S Event Registration Now Open
More than 2,000 years ago, humanity gazed up at the stars, probing the laws of the cosmos. Three centuries ago, scientists built the modern scientific framework through experimentation and mathematics. Every leap in scientific development has been accompanied by new tools, new methods — and shifts in how humans explore the unknown.
Wanwu Capital's Bio-Manufacturing Industry Partners Conference Convenes in Shanghai! Shanghai's First Bio-Manufacturing Industry Fund Launches, Partners Discuss the Golden Decade
On the afternoon of October 23, 2025, the "Sheng Yan Wan Wu | Bio-Manufacturing Industry Value Partners Conference," co-hosted by Dalton Venture and OPM Biosciences [688293], was held in Shanghai. Centered on the theme "Sheng Yan Wan Wu" (Life Begets All Things), the conference brought together representatives from government agencies, scholars from research institutes, industry-leading entrepreneurs, fund investors, and ecosystem partners to explore cutting-edge trends in bio-manufacturing and pathways for industrial collaboration.
Qiming Venture Partners' 16th RMB Fund Annual Meeting and Investor Summit Successfully Held in Shanghai
China's high-quality companies have reached a valuation level that's become genuinely attractive.
